Patents Assigned to BIORESTORATIVE THERAPIES, INC.
-
Patent number: 11851682Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment, the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.Type: GrantFiled: June 15, 2021Date of Patent: December 26, 2023Assignee: BIORESTORATIVE THERAPIES, INC.Inventors: Francisco Javier Silva, Mark Weinreb, Amit N. Patel, David A. Bull
-
Patent number: 11667892Abstract: An isolated human brown adipose tissue stem cell line. In one embodiment, the isolated human brown adipose tissue stem cell line expresses the markers CD9, SSEA4, CD44, CD90, CD166, CD73, but not CD14, CD34, CD45 or STRO-1. In another embodiment, the isolated human brown adipose tissue stem cell line expresses the genes UCP1, PPARGC1A, NRF1, FOXC2, CREB1, SIRT3, and WNT5A (REFX). In still another embodiment, the isolated human brown adipose tissue stem cell line is capable of differentiating into osteoblasts, chondrocytes, and adipocytes.Type: GrantFiled: February 2, 2021Date of Patent: June 6, 2023Assignee: BIORESTORATIVE THERAPIES, INC.Inventor: Francisco Javier Silva
-
Patent number: 11066646Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment, the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.Type: GrantFiled: March 2, 2018Date of Patent: July 20, 2021Assignee: BIORESTORATIVE THERAPIES, INC.Inventors: Francisco Javier Silva, Mark Weinreb, Amit N. Patel, David A. Bull
-
Patent number: 10941383Abstract: An isolated human brown adipose tissue stem cell line. In one embodiment, the isolated human brown adipose tissue stem cell line expresses the markers CD9, SSEA4, CD44, CD90, CD166, CD73, but not CD14, CD34, CD45 or STRO-1. In another embodiment, the isolated human brown adipose tissue stem cell line expresses the genes UCP1, PPARGC1A, NRF1, FOXC2, CREB1, SIRT3, and WNT5A (REFX). In still another embodiment, the isolated human brown adipose tissue stem cell line is capable of differentiating into osteoblasts, chondrocytes, and adipocytes.Type: GrantFiled: November 7, 2018Date of Patent: March 9, 2021Assignee: BIORESTORATIVE THERAPIES, INC.Inventor: Francisco Javier Silva
-
Patent number: 10597638Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.Type: GrantFiled: July 1, 2013Date of Patent: March 24, 2020Assignee: BIORESTORATIVE THERAPIES, INC.Inventors: Francisco Javier Silva, Mark Weinreb, Amit N. Patel, David A. Bull
-
Patent number: 10167449Abstract: An isolated human brown adipose tissue stem cell line. In one embodiment, the isolated human brown adipose tissue stem cell line expresses the markers CD9, SSEA4, CD44, CD90, CD166, CD73, but not CD14, CD34, CD45 or STRO-1. In another embodiment, the isolated human brown adipose tissue stem cell line expresses the genes UCP1, PPARGC1A, NRF1, FOXC2, CREB1, SIRT3, and WNT5A (REFX). In still another embodiment, the isolated human brown adipose tissue stem cell line is capable of differentiating into osteoblasts, chondrocytes, and adipocytes.Type: GrantFiled: April 17, 2014Date of Patent: January 1, 2019Assignee: BIORESTORATIVE THERAPIES, INC.Inventor: Francisco Javier Silva
-
Patent number: 9133438Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.Type: GrantFiled: June 28, 2012Date of Patent: September 15, 2015Assignee: BIORESTORATIVE THERAPIES, INC.Inventors: Francisco Silva, Mark Weinreb, Amit N. Patel, David A. Bull
-
Publication number: 20140212875Abstract: A method of distinguishing a brown adipose cell from a white adipose cell. In one embodiment the method includes measuring the expression level of one or more genes in an adipose cell; comparing the measured expression levels to a control, and correlating the expression level of the one or more genes to an identity as a white adipose cell or a brown adipose cell. In one embodiment the one or more genes are selected from the genes listed in FIG. 4C. In another aspect the invention relates to a method of differentiating an adipose stem cell. In one embodiment the method includes inducing differentiation of an adipose stem cell in vitro; and distinguishing the differentiated stem cell. In another embodiment the inducing is performed by contacting the adipose stem cell with a brown adipose cell differentiation media.Type: ApplicationFiled: January 24, 2014Publication date: July 31, 2014Applicant: BioRestorative Therapies, Inc.Inventor: Francisco Javier Silva
-
Publication number: 20130071360Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.Type: ApplicationFiled: June 28, 2012Publication date: March 21, 2013Applicant: BIORESTORATIVE THERAPIES, INC.Inventors: Francisco Silva, Mark Weinreb, Amit N. Patel, David A. Bull